The middle yellowish layer is dense with agents that are believed to stop an arthritic agent known as interleukin 1, which causes degeneration of the joints and the breakdown of cartilage.

Use of higher doses of radioiodine reduces the incidence of treatment failure, with penalty for higher response to treatment consisting mostly of higher rates of eventual hypothyroidism which requires hormone treatment for life.